XL Lin serves as Director of Market Development for Esco Group.
He founded and manages the Esco Pharma Division within the Esco group of companies in 2009 developing the companies' very first cGMP downflow/containment booths and isolation systems from concept development to sales, project management, site-work, and validation.
Under his leadership, Esco Pharma has expanded from just a small division to now having 3 factories globally in USA/UK and Singapore. He brings his unique skillset in social entrepreneurship, market development, strategic product development, globally alliance networking, sales/contract management, clean air/containment facility, and systems design/integration into Esco VacciXcell. XL Lin graduated with a Bachelor of Sciences from University of Sydney and he is currently pursuing various options for further studies.